Research saved Simon’s life – it could save others too

Research / 06 May, 2025

Simon’s story

Simon never imagined that a bit of heartburn would be the first sign of something far more serious.

“I thought it was the usual – too much work, poor diet and maybe too much red wine,” says Simon. “Even my GP thought it was nothing to worry about.”

But Simon persisted. A second opinion led to a devastating diagnosis: aggressive non-Hodgkin’s lymphoma. It was September 2018. He was 52, a Qantas captain, husband to Catherine and dad to teenage daughter Bianca.

“I went from being fit and flying planes to facing the fight of my life,says Simon.

Running out of options

Simon’s initial treatment began at Icon Cancer Centre, where his care team moved quickly to begin chemotherapy. At first, Simon responded well to chemotherapy. But then the cancer came back – not once, but twice.

“My doctors said I was running out of options. Running out of time,” he says.

Simon’s last hope was a promising breakthrough in cancer treatment, CAR T-cell therapy – a form of immunotherapy.

Like many medical advances, it exists only because of research.

“CAR T-cell therapy didn’t even exist a decade ago,” says Simon. “Without research, it wouldn’t exist now, and I wouldn’t be here.”

“Without research… I wouldn’t be here.”

The power of a breakthrough

As CAR T-cell therapy wasn’t available in Australia at the time – and remains limited to a few public hospitals here – Simon travelled to Boston for treatment.

The therapy worked. Simon has now been in remission for five years. He’s back in the cockpit doing what he loves and cherishing every moment with his family.

“When you come that close to losing everything, you don’t take anything for granted. I owe my life to research and to the people who support it,” he says.

“I owe my life to research and to the people who support it.”

Every treatment starts with research

Simon’s story is a powerful reminder that every effective cancer treatment available today started as an idea – one that needed funding, testing and time to develop.

It’s a striking example of how breakthroughs happen when research is supported over time.

That’s why ICF is committed to funding innovative research led by Icon Cancer Centre clinicians – so that more patients like Simon have access to the next generation of treatments.

 

“If supporting research means someone else gets to live, then that’s something worth striving for,” says Simon.

Your donation today helps fund the research that leads to tomorrow’s cures.

Please give generously.

Donate Now

Search

Quick links
Donate